Evidence map›Paper›PMID 25848706›Full record

ArticleBMC public health2015

From pills to patients: an evaluation of data sources to determine the number of people living with HIV who are receiving antiretroviral therapy in Germany.

Daniel Schmidt, Christian Kollan, Matthias Stoll, Hans-Jürgen Stellbrink, Andreas Plettenberg, Gerd Fätkenheuer, Frank Bergmann, Johannes R Bogner, Jan van Lunzen, Jürgen Rockstroh and 9 more

Abstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022
    Article
  2. Analysis of HIV pre-exposure prophylaxis (PrEP) needs and PrEP use in Germany among men who have sex with men.Zeitschrift fur Gesundheitswissenschaften = Journal of public health · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Daniel Schmidt
Christian Kollan
Matthias Stoll
Hans-Jürgen Stellbrink
Andreas Plettenberg
Gerd Fätkenheuer
Frank Bergmann
Johannes R Bogner
Jan van Lunzen
Jürgen Rockstroh
Stefan Esser
Björn-Erik Ole Jensen
Heinz-August Horst
Carlos Fritzsche
Andrea Kühne
Matthias an der Heiden
Osamah Hamouda
Barbara Bartmeyer
ClinSurv Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThis study aimed to determine the number of people living with HIV receiving antiretroviral therapy (ART) between 2006 and 2013 in Germany by using the available numbers of antiretroviral drug prescriptions and treatment data from the ClinSurv HIV cohort (CSH).

methodsThe CSH is a multi-centre, open, long-term observational cohort study with an average number of 10.400 patients in the study period 2006-2013. ART has been documented on average for 86% of those CSH patients and medication history is well documented in the CSH.

resultsThe proportion of CSH patients receiving TCMs increased continuously over time (from 85% to 93%; 2006-2013). In contrast, treatment interruptions declined remarkably (from 11% to 2%; 2006-2013). The total number of HIV-infected people with ART experience in Germany increased from 31,500 (95% CI 31,000-32,000) individuals to 54,000 (95% CI 53,000-55,500) over the observation period (including 16.3% without SHI and persons who had interrupted ART). An average increase of approximately 2,900 persons receiving ART was observed annually in Germany.

conclusionsA substantial increase in the number of people receiving ART was observed from 2006 to 2013 in Germany.

Indexed as

AdultAnti-HIV AgentsCohort StudiesDatabases, FactualFemaleGermanyHIV InfectionsHumansMaleMiddle AgedPharmaciesPrevalenceAnti-HIV Agents

Identifiers

PMID25848706
PMCPMC4369891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.